McMaster-based biotech company to receive $105 million for cancer therapy research
by from on (#4CBXP)
Fusion Pharmaceuticals is set to receive one of the largest-ever private investments in a Canadian biotech spin-out company.
External Content
| Source | RSS or Atom Feed |
| Feed Location | http://rss.metroland.com/9/article/hamilton |
| Feed Title | |
| Feed Link | http://rss.metroland.com/ |
| Reply | 0 comments |